Our Team
Chief Operations Officer: Mark Drew, Ph.D.
Dr. Drew, Ph.D. completed his doctorate degree in synthetic organic chemistry from the University of Manchester Institute of Science and Technology, UK . He completed postdoctoral research in Asymmetric Synthesis at IUPUI, Indiana, USA. Dr. Drew is currently the translation Project Manager to the Center for Innovation In Brain Science, University of Arizona. From 2000, he has been a medicinal chemist/Lead Research Scientist at Array BioPharma, Sanofi Pharmaceuticals and Icagen, Inc. working on discovery and optimization projects for oncology, inflammatory and rare disease indications. Dr. Drew is a USPTO licensed patent agent and holds a current Project Management Professional Certification. He will serve as Chief Operations Officer for NeuTherapeutics.